Increased rate of opsonization of zymosan by serum from patients with psoriasis.
D006801:Humans; D008727:Methotrexate / Q000627:therapeutic use; D009504:Neutrophils / Q000378:metabolism; D009895:Opsonin Proteins / Q000096:biosynthesis*; D010101:Oxygen Consumption; D010587:Phagocytosis; D011565:Psoriasis / Q000097:blood* / Q000188:drug therapy; D015054:Zymosan / Q000097:blood*
D009895:Opsonin Proteins; D015054:Zymosan; D008727:Methotrexate